Literature DB >> 29128015

Primary Graft Dysfunction After Lung Transplantation.

Mary K Porteous1, James C Lee2.   

Abstract

Primary graft dysfunction is a form of acute injury after lung transplantation that is associated with significant short- and long-term morbidity and mortality. Multiple mechanisms contribute to the pathogenesis of primary graft dysfunction, including ischemia reperfusion injury, epithelial cell death, endothelial cell dysfunction, innate immune activation, oxidative stress, and release of inflammatory cytokines and chemokines. This article reviews the epidemiology, pathogenesis, risk factors, prevention, and treatment of primary graft dysfunction.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute lung injury; Ischemia-reperfusion injury; Lung transplantation; Primary graft dysfunction

Mesh:

Year:  2017        PMID: 29128015     DOI: 10.1016/j.ccm.2017.07.005

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  18 in total

1.  Necrostatin-1 Synergizes the Pan Caspase Inhibitor to Attenuate Lung Injury Induced by Ischemia Reperfusion in Rats.

Authors:  Liangrong Wang; Baihui Chen; Xiangqing Xiong; Shunli Chen; Lida Jin; Meizhen Zhu
Journal:  Mediators Inflamm       Date:  2020-10-24       Impact factor: 4.711

2.  Risk of primary graft dysfunction following lung transplantation in selected adults with connective tissue disease-associated interstitial lung disease.

Authors:  Jake G Natalini; Joshua M Diamond; Mary K Porteous; David J Lederer; Keith M Wille; Ann B Weinacker; Jonathan B Orens; Pali D Shah; Vibha N Lama; John F McDyer; Laurie D Snyder; Chadi A Hage; Jonathan P Singer; Lorraine B Ware; Edward Cantu; Michelle Oyster; Laurel Kalman; Jason D Christie; Steven M Kawut; Elana J Bernstein
Journal:  J Heart Lung Transplant       Date:  2021-01-23       Impact factor: 10.247

Review 3.  Protective effects of molecular hydrogen on lung injury from lung transplantation.

Authors:  Lini Quan; Bin Zheng; Huacheng Zhou
Journal:  Exp Biol Med (Maywood)       Date:  2021-04-25

4.  Extracellular histones play a pathogenic role in primary graft dysfunction after human lung transplantation.

Authors:  Yang Jin; Meng Sun; Xin Lv; Xingan Wang; Gening Jiang; Chang Chen; Zongmei Wen
Journal:  RSC Adv       Date:  2020-03-27       Impact factor: 4.036

5.  Effects of AntagomiRs on Different Lung Diseases in Human, Cellular, and Animal Models.

Authors:  Giuseppe Murdaca; Alessandro Tonacci; Simone Negrini; Monica Greco; Matteo Borro; Francesco Puppo; Sebastiano Gangemi
Journal:  Int J Mol Sci       Date:  2019-08-13       Impact factor: 5.923

6.  Long non-coding RNA X-inactive specific transcript silencing ameliorates primary graft dysfunction following lung transplantation through microRNA-21-dependent mechanism.

Authors:  Jiwei Li; Li Wei; Zhijun Han; Zhong Chen; Quan Zhang
Journal:  EBioMedicine       Date:  2020-01-22       Impact factor: 8.143

7.  The Conversional Efficacy of Ex Vivo Lung Perfusion and Clinical Outcomes in Patients Undergoing Transplantation of Donor Lungs by Ex Vivo Lung Perfusion: A Meta-Analysis.

Authors:  Qiuping Luo; Linhai Zhu; Yiqing Wang; Luming Wang; Wang Lv; Jian Hu
Journal:  Ann Transplant       Date:  2019-12-27       Impact factor: 1.530

8.  Early Graft Dysfunction after Lung Transplantation.

Authors:  Justin Rosenheck; Colleen Pietras; Edward Cantu
Journal:  Curr Pulmonol Rep       Date:  2018-10-22

Review 9.  The potential of ex vivo lung perfusion on improving organ quality and ameliorating ischemia reperfusion injury.

Authors:  Jasper Iske; Christopher A Hinze; Jawad Salman; Axel Haverich; Stefan G Tullius; Fabio Ius
Journal:  Am J Transplant       Date:  2021-08-24       Impact factor: 8.086

10.  Incidence of primary graft dysfunction is higher according to the new ISHLT 2016 guidelines and correlates with clinical and molecular risk factors.

Authors:  Daoud Daoud; Lourdes Chacon Alberty; Qi Wei; Camila Hochman Mendez; Muhammad Hassan Masood Virk; Jonathan Mase; Peter Jindra; Matthew Cusick; Hyewon Choi; Natalie Debolske; Luiz C Sampaio; Doris A Taylor; Gabriel Loor
Journal:  J Thorac Dis       Date:  2021-06       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.